京东健康互联网医院
网站导航

沈阳医学院奉天医院,沈阳市中心医院,沈阳市手外科医院滑精病专家

简介:

沈阳医学院附属中心医院(沈阳市中心医院、沈阳市手外科医院),是沈阳市西部区域医疗卫生服务中心。始建于1956年,1983年被确定为沈阳市中心医院,1987年划归为沈阳医学院,1993年评定为三级甲等综合医院。是一所集医疗、教学、科研、预防、保健、康复为一体,以创伤外科、手足踝外科、急诊急救、呼吸与危重症为特色的大型综合性三级甲等高等医学院校附属医院,为国家博士后科研工作站,国家级住院医师规范化培训基地,国家医师资格考试实践技能考试基地和考官培训基地,国家老年疾病临床医学研究中心沈阳分中心,国家显微外科技能培训中心,国家药物临床试验机构,国家级胸痛中心、高级卒中中心,国家首批肺癌规范诊疗质控试点单位,美国心脏协会心血管急救培训中心。辽宁省全科医学临床培训与基层实践基地、全科医师转岗临床培训基地,沈阳医学院临床医学专业硕士培养教学基地,沈阳市手足外科临床医学研究中心,沈阳市慢阻肺管理与防治临床医学研究中心,沈阳市基层卫生人员培训中心,沈阳市创伤、胸痛、卒中、危重孕产妇救治中心,是沈阳市医疗、护理、检验、病理、血液净化专业质控中心。医院位于沈阳市铁西区,占地面积6.4万平方米,建筑面积16万平方米。开放床位2000张,年门诊量100万人次,年收治病人6万人次,年手术2.5万例。资产总值16.9亿元,医疗设备5000余台件,其中3.0T核磁共振、256层螺旋CT等100万元以上设备45台件。医院教职员工2169人,专业技术人员2026人,副高级职称以上人员634人,硕博士536人,博士生导师1人,硕士生导师75人。国务院特殊津贴获得者1人,沈阳市优秀专家3人,辽宁省百、千、万人才14人,沈阳市百、千、万人才3人。有532人次在国家级、省级各类专业委员会任职。近年来,获批各级各类科研项目252项,科研经费1400余万元。国家自然科学基金3项、省级科研项目57项、市级科研项目41项。获发明专利15项。辽宁省继续医学教育项目47项,举办学术会议100余次。共发表各级各类论文753篇,其中SCI64篇,北大核心103篇。医院拥有39个教研室,65个临床与医技科室,有2个省级重点实验室(辽宁省手外科组织工程重点实验室、辽宁省慢性阻塞性肺疾病医学与工程重点实验室),4个省级重点专科(手外科、呼吸科、检验科、急诊医学中心),13个市级重点专科(手外科、呼吸科、检验科、病理科、护理专业、肾内科、神经内科、骨创伤外科、胃肠外科、心血管内科、重症医学科、产科、感染科)和3个医学院重点学科(手外科、呼吸科、骨外科)。2个辽宁省医学会专业委员会主委单位,7个沈阳医学会专业委员会主委单位,2个沈阳市临床医学研究中心(沈阳市手足外科临床医学研究中心、沈阳市慢阻肺管理和防治临床医学研究中心)。医院和复旦大学附属华山医院徐文东教授、北京同仁医院张建中教授、北京协和医院田野教授等国内知名医院专家建立9个专家工作站,致力于打造沈阳市微创治疗中心、数字化骨科3D打印治疗中心、关节镜治疗中心、足踝矫形中心和肢体重建中心。手外科是东北领先,国内先进,国际水平的学科,1977年成立,从无到有,在几代人的不懈努力下,发展壮大为五个临床病区300张床位,附有手外科研究所,《实用手外杂志》编辑部。1986年完成世界首例“利用自体废弃小腿修复前臂缺损手再植术”、1988年完成世界第三例“十指离断再植全部成活手术”、“双上肢离断再植术”。能开展各类手部复杂创伤、全型手再造技术、晚期功能重建、肿瘤及先天畸形等疾病的诊治,近年来在腕关节镜技术和颈7神经移位术治疗偏瘫方面取得显著成效。医院多次承担沈阳地区重大、群体外伤抢救和突发公共卫生事件的诊治,抢救成功率处于国内先进水平,综合实力得到行业内及患者的高度评价,2016年成功诊断辽宁省首例人感染H7N9患者。汶川地震、玉树地震、新冠肺炎等危急时刻,医院均选派医疗队深入灾区开展救治工作。医院先后获得全国医疗保险服务规范示范医院、省市文明单位、省卫生系统规范化先进集体、市“十佳医院”、市五一劳动奖状、沈阳公共服务百姓口碑榜金榜单位等荣誉称号。。

尚伟光 副主任医师

小儿内科常见病,发热,惊厥,感染性疾病,慢性咳嗽,食物过敏,支气管哮喘,支气管肺炎,反复呼吸道感染,腹泻,腹痛,新生儿感染性疾病,新生儿黄疸,抽动症,免疫力低下,儿童保健等。

好评 99%
接诊量 968
平均等待 15分钟
擅长:小儿内科常见病,发热,惊厥,感染性疾病,慢性咳嗽,食物过敏,支气管哮喘,支气管肺炎,反复呼吸道感染,腹泻,腹痛,新生儿感染性疾病,新生儿黄疸,抽动症,免疫力低下,儿童保健等。
更多服务
刘万智 副主任医师

干眼症、结膜病、角膜病、巩膜病、葡萄膜病、视网膜病、白内障、青光眼、眼睑病及整形、眼外伤等

好评 100%
接诊量 1252
平均等待 2小时
擅长:干眼症、结膜病、角膜病、巩膜病、葡萄膜病、视网膜病、白内障、青光眼、眼睑病及整形、眼外伤等
更多服务
牛庆飞 主任医师

足踝部畸形矫正,包括拇外翻、扁平足、高弓足、马蹄内翻足等畸形;足踝部运动损伤关节镜微创治疗,包括踝关节扭伤、距骨软骨损伤、踝关节不稳、踝关节韧带损伤修复重建等;足踝部创伤,包括足踝部各种骨折、lisfranc损伤、跟腱断裂等;足踝部相关疾病,包括骨性关节炎、类风湿足、糖尿病足、 Freiberg病、夏科氏关节、CMT综合征等。

好评 99%
接诊量 827
平均等待 1小时
擅长:足踝部畸形矫正,包括拇外翻、扁平足、高弓足、马蹄内翻足等畸形;足踝部运动损伤关节镜微创治疗,包括踝关节扭伤、距骨软骨损伤、踝关节不稳、踝关节韧带损伤修复重建等;足踝部创伤,包括足踝部各种骨折、lisfranc损伤、跟腱断裂等;足踝部相关疾病,包括骨性关节炎、类风湿足、糖尿病足、 Freiberg病、夏科氏关节、CMT综合征等。
更多服务
马莉 主任医师

擅长脑血管病诊断和治疗,尤其是急性脑梗死的溶栓,癫痫的诊断和用药选择,头晕,头痛等神经内科的常见病及多发病的诊断和治疗。

好评 100%
接诊量 1
平均等待 -
擅长:擅长脑血管病诊断和治疗,尤其是急性脑梗死的溶栓,癫痫的诊断和用药选择,头晕,头痛等神经内科的常见病及多发病的诊断和治疗。
更多服务
李洪秋 主任医师

1.关节镜微创手术、运动康复;2.复杂创伤及骨折术后并发症;3.骨质疏松与骨关节炎的诊治;

好评 -
接诊量 -
平均等待 -
擅长:1.关节镜微创手术、运动康复;2.复杂创伤及骨折术后并发症;3.骨质疏松与骨关节炎的诊治;
更多服务
何晓欣 副主任医师

脑血管病,运动障碍性疾病

好评 -
接诊量 -
平均等待 -
擅长:脑血管病,运动障碍性疾病
更多服务
潘广雯 副主任医师

脑血管病

好评 -
接诊量 -
平均等待 -
擅长:脑血管病
更多服务
包蕾 副主任医师

急慢性脑血管疾病,认知障碍,记忆力下降,癫痫的诊治。

好评 -
接诊量 -
平均等待 -
擅长:急慢性脑血管疾病,认知障碍,记忆力下降,癫痫的诊治。
更多服务
陈莹 副主任医师

擅长癫痫、头晕头痛、急性脑血管病、面神经麻痹、中枢神经系统感染等神经系统常见病的诊疗。

好评 -
接诊量 -
平均等待 -
擅长:擅长癫痫、头晕头痛、急性脑血管病、面神经麻痹、中枢神经系统感染等神经系统常见病的诊疗。
更多服务
张艳 副主任医师

脑血管病,周围神经疾病,癫痫

好评 -
接诊量 -
平均等待 -
擅长:脑血管病,周围神经疾病,癫痫
更多服务

患友问诊

男性23岁,近期出现滑精,一周一次,无梦,伴有腰酸乏力,尿急。
27
2024-10-31 06:15:08
肾虚阳痿,滑精早泄,性功能减退,求用药建议。
17
2024-10-31 06:15:08
性生活时间短,怀疑肾虚。
4
2024-10-31 06:15:08
40岁男性,出现男性功能问题,滑精时间短,寻求健康指导。
53
2024-10-31 06:15:08
腰酸乏力,中医建议补肾固精,询问适合的补肾药品。
2
2024-10-31 06:15:08
30岁男性,虚肾滑精,影响生育,询问用药和生活建议。
55
2024-10-31 06:15:08
患者出现阳痿滑精、腰膝酸冷、气短神疲等症状,疑问三肾丸浓缩丸的使用和注意事项。
30
2024-10-31 06:15:08
腰膝酸软,夜间睡眠不好,询问肾虚用药建议。
21
2024-10-31 06:15:08
肾虚阳痿,滑精早泄,想咨询七鞭回春乐胶囊是否适用。
49
2024-10-31 06:15:08
患者疑问是否可以用中药调理肾精亏损和元阳不足引起的阳痿滑精问题,并询问三肾丸的用法和适应证,以及对手淫和敏感问题的辅助功效。
53
2024-10-31 06:15:08

科普文章

滑精即在清醒的状态下,在非性生活或手淫时射精,滑精应当与遗精相鉴别,遗精也是在非性生活或手淫时射精,但遗精是在睡眠中射精,二者的发病原因是大致相同。偶然的滑精并不是病理现象,正所谓的精满自溢,尤其是青春发育期男性最为常见。频繁的滑精,则为肾气亏虚、精关不固所致,一般可以通过口服补肾溢精、固摄精液的中药或中成药调治,平时饮食以清淡为主。

 

 

滑精属于遗精的一种,不过它比遗精严重,遗精不频繁的话属正常现象,但是滑精则属于一种病态症状,因此当男性出现滑精现象时,要引起重视,及时治疗,而治疗滑精的方法有很多,有滑精现象的男性朋友可以了解一下它的疗法,根据自己的情况来选择适合自己的病情的疗法。


滑精是由于肾阴肾阳俱虚而引起的,主要是一些男性长期纵欲或长期手淫,从而导致肾阴亏虚,然后持续肾阴损伤过甚而损及肾阳,导致肾阴阳俱虚,最后出现无梦而遗的滑精现象。另外也有的男性由于体质虚弱,长期患有慢性病或腰脊髓刺激性损害、过度疲劳、精阜发炎等情况,也可引起滑精。那么男人滑精怎么办?下面来给滑精者介绍一些治疗方法。


1、刺猬皮、炒炭存性,研磨后取适量在睡前服用,对于久遗不止的滑精者适宜;


2、清心丸:黄柏、冰片,各适量,和面糊为丸后服用,一天服三次,对于青壮年单纯火盛滑精者适宜;


3、金樱子、芡实、白莲花蕊、煅龙骨,各适量,把它们研细未后米糊为丸,每天取适量用盐酒汤送下,适合肾虚之滑精者;


4、泽泻适量,加水煎后每天服一次,适合实证之滑精;


5、木耳适量,把它焙干研未,和白砂糖适量和匀用温水送服,可治滑精;

 


6、荷叶适量,研为细开后取适量用酒调服,适合湿热下注滑精者;


7、气功治疗滑精:固精功法,可治各种遗精滑精,还有保健功效、擦丹田,有强精固肾作用,也可缓解滑精现象。


男人滑精怎么办呢?当然是及时治疗了,而治疗男人滑精的方法有很多,上面的这些中药偏方疗法对于不同类型的滑精现象就有一定的调治作用,对于有滑精现象的男性,不妨可以根据自己的情况来选择合适的疗法,以尽快消除滑精现象,防止长时间的滑精影响到身体健康,导致肾虚加重而引起更多不适症状。

有梦而遗者名为"梦遗",无梦而遗,甚至清醒时精液自行滑出者为"滑精"。直肠指诊,前列腺B超,精液常规及前列腺液检查可助病因诊断。

 

滑精的原因比较复杂,主要还是因为一些疾病原因造成的,比如交感神经控制力下降,或者说一些慢性疾病,另外如果人员长期有手淫的习惯,或者精神状态不佳、长期抑郁都有可能诱发滑精的症状表现,一定要及时到医院检查,并且正规的治疗,加强良好的调理。

 


滑精和我们平时说的还是有一定的区别,滑精通常是指无梦而遗,就是在没有性冲动的情况下,出现遗精的症状表现。出现这样的症状对人的危害很大,常会导致人神情疲惫,注意力不集中,引起心慌气短、疲乏劳累,我们了解一下这方面的内容。


导致滑精的原因有很多,多是因为一些慢性疾病造成的。比如说有严重腰脊髓炎症损害,有比较严重的神经衰弱,交感神经控制力下降,或者是平时过度的疲劳,长期的神经紧张,或者青少年有长期的手淫习惯,都有可能导致这样的症状表现。


当男性出现滑精的症状表现的时候,应该及时到医院进行检查,找到病因然后对症治疗,并且在平时要注重饮食调养,良好的饮食调养有利于固精补肾之功效,另外平时要保持充分的休息,最好是戒烟戒酒,尤其在心态方面也要注意,一定要乐观。


芡实核桃莲子粥具有一定的调养的功效,对于滑精的症状表现有一定的改善的作用,准备核桃仁,准备莲子肉各30克左右。先用温水泡20分钟左右,然后加入大红枣十颗。煮熟以后加入欠粉勾芡,最后放入红糖,每天适当的吃一些。

 


莲子煲猪肚也有不错的调养作用,准备莲子二两,准备猪肚半斤,先把莲子清洗干净,然后劈开,去掉莲子心,把猪肚洗净,切成小块儿,放入水中煲汤,加少许盐和味精。有不错的补肾固精,预防滑精的效果。


以上简单的了解了滑精的原因有哪些,如何做好饮食方面的调养,滑精对人的危害还是很大的,当出现这样的症状的时候,一定要及时到医院进行检查,平时要改正以前不当的生活习惯,注重饮食调养,保持充分的休息,保持乐观的心态等等。

#滑精病#滑精病
57

首先我们谈谈什么叫滑精?滑精又俗称“滑泄 ”,指人夜间无梦而遗,甚至在清醒状态时精液自动滑出的病症。目前从临床证型看,滑精多表现肾阴肾阳俱虚之证。这是由于长期手淫或长期纵欲,起初表现为肾阴亏虚,时间长了表现为肾阴损伤过甚而损及肾阳,从而表现肾阴阳俱虚,出现无梦而遗的滑精现象。此外,严重的神经衰弱、过度疲劳或精神紧张等亚健康状态以及慢性疾病都可能引起滑精。

其次我们谈谈什么是早泄,早泄与滑精最明显的区别就是早泄是指性交,无性交不能算早泄,早泄一般认为插入阴道时间低于 2 分钟,但是仅仅从时间多不科学准确,也要从对方的满意度,也就是对方如果有半数以上的性生活中,没有性高潮也可称之为早泄,早泄有原发性早泄、继发性早泄、境遇性早泄之分,中医关于早泄重在辨证论治,通常把早泄辨证分为:

  • 肝经湿热:头晕目眩,口苦咽干,心烦易怒,阴囊湿痒,小便黄赤等症状;
  • 阴虚火旺:阳事易举,伴五心烦热,潮热盗汗,腰膝酸软等症状;
  • 肾气不固:性欲减退,腰膝酸软,小便清长或不利等症状。

当然临床上很少有单独的证,常常兼夹出现,如肾气不固伴有湿热下注,阴阳失调,心肾不交等,因此一定要区分不同证型,为临床治疗提供准确的治疗依据。

#滑精病
7

   首先,我们一定要养成良好的生活习惯,避免长时间的劳累紧张,压力过大,尤其不能长时间熬夜,手淫过度,性生活过度等等造成身体体质下降的一些因素。

      其次。避免长时间大量的吸烟饮酒,同时心情舒畅,加强锻炼增强体质是预防这个疾病的最有力武器。

       同时,在饮食上多吃含有大量维生素等食品,比如说各种水果,各种干果以及蔬菜等等。

       必要的情况下,可以吃一些中成药进行预防治疗也是帮助很大的。这个时候就需要找专业中医师把脉进行四诊合参,辨证用药比较好,千万不要自己购药,尤其不要吃一些不靠谱的保健品。

#滑精病#滑精病
8

   一般情况下,临床上如果没有结婚或者没有性生活,或者没有手淫的话出现遗精的次数,一个月不超过2到3次就属于正常,但是滑精属于精的比较严重阶段,不论出现次数多少都都是不正常的。出现这个病症往往是体质虚弱,或者长期患有某些慢性病或者脊髓一些损伤,甚至一些严重的神经衰弱,过度疲劳,甚至是过度的手淫熬夜劳累过度等等造成的体质下降的一个表现。

        所以说在临床上如果出现这个问题,一定要引起足够的重视,对症治疗的同时一定要养成良好生活习惯,增强体质,就可以防止这个疾病的反复发作,或对身体的进一步损伤。

病症: 胃癌 恶性黑色素瘤

患者:李女士

年龄:70岁

罹患癌症,毫无疑问对每个人都是重大打击。而如果一位患者不幸同时罹患两种癌症,我们可以想象得出他的心情会是怎样的沉重。

但时至今日,癌症早已不再是什么“不治之症”,很多良好的治疗方法,可帮助患者迈过重重困境,预后得到极大提升。

不仅如此,在医疗全球化的今天,中国患者也能通过“海外二诊”服务,快速触达到国际权威专家资源,为自己的治疗保驾护航!

今天的案例主人公李女士,正是一位“海外二诊”的受益者。我们来一起看看她的故事。*为保护隐私,文中患者个人信息均已经脱敏处理。

70岁的李女士在去年年底,因脚底疼痛去医院看病,结果发现脚后跟有一个1厘米的黑色肿物。医生判断是冻疮,于是开了点外用药,李女士也就没有再放在心上。

大概4个月后,真正的噩梦降临:李女士通过影像检查,被诊断为胃癌,而且有了淋巴结转移。 她还出现了多次呕血,病情非常危急。很快,医生为她实施了全胃切除。令人意想不到的是,几天后通过检查,医生发现李女士后脚跟的肿物竟然也是癌症——恶性黑色素瘤。于是大概2个月后,医生又切除了她的足底肿瘤。 

为了降低复发风险,李女士开始了3个周期的化疗联合免疫治疗(替吉奥联合纳武单抗)。

虽然该做的都已做完,但对于李女士来说,恐惧感还远未被消除。因为癌症最令人恐惧的,是其具有“复发转移”的能力 。一旦癌症再次袭来,李女士不知道自己该如何应对。另外,两种癌症的治疗以及术后辅助药物治疗,也让李女士遭遇了一些副作用。比如腹泻、味觉障碍还有体重明显下降的问题。这些对于已经70岁的李女士来说,都很影响生活质量,所以迫切需要解决。

在本次的国际专家“海外二诊”服务中,李女士预约的是来自日本某知名综合性医院肿瘤中心的外科部长医生,他的专长领域既包括肿瘤外科,又包括各类癌症药物疗法、姑息治疗,是一位“内外兼修”的权威专家。在充分了解了李女士既往的病情和治疗经过后,医生很快通过远程会诊的方式,为患者详细解答了当前她的所有问题。

1、 未来如果转移或复发了该怎么办?  

医生:假如您未来不幸出现转移或复发,那么化疗是核心治疗手段。对于单发的孤立转移灶,可以选择手术、放疗来进行局部治疗。

具体化疗方案选择,我按使用的先后顺序列出了3类,当前面的方案失效后,可更换为后面的方案。

一类方案:化疗联合/不联合免疫方案  

  • CAPOX (卡培他滨+奥沙利铂)±O药(即免疫药物纳武单抗)
  • SOX (替吉奥+奥沙利铂)±O药
  • FOLFOX (5-FU+奥沙利铂)±O药

二类方案:化疗联合/不联合抗血管药物方案  

  • Taxane (紫杉醇/白蛋白结合型紫杉醇/多西紫杉醇)±雷莫芦单抗

三类方案:化疗方案  

  • 曲氟尿苷/盐酸替吡嘧啶
  • 伊立替康

  2、N K细胞疗法是否对我有帮助?副作用是否可控?   X医生:目前尚没有证据表明NK细胞疗法对癌症有效,因此不予推荐。

3、口服替吉奥会腹泻,是否需要调整方案?   II/III期胃癌患者术后采用辅助治疗方案,分别为:

  • 替吉奥口服 1 年(口服 4 周,停药 2 周,共 8 个疗程或口服 2 周,停药 1 周,共 16个疗程)
  • CAPOX (卡培他滨+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)
  • SOX (替吉奥+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)

这三种方案中,替吉奥方案和CAPOX方案等效,但SOX要优于替吉奥。另外,胃癌术后直接使用纳武单抗免疫治疗无意义。

替吉奥确实会出现腹泻等代表性不良反应,患者可以考虑对症治疗,比如调节肠道的药物、止泻药等缓解副作用。如果副作用太严重,那么可以考虑减少药物剂量。

替吉奥的标准用药剂量为120mg,但用量低于80mg无法达到预期效果。如果当前患者用药为100mg,那么为了降低副作用,可以减少剂量到80mg;但如果目前剂量已经是80mg,则无法进一步降低剂量,此时考虑更换方案为CAPOX方案替代。 如果不良反应严重到干扰日常生活,则患者可以选择停药,持续观察病情变化。

对于无淋巴结转移的II期B和II其C的患者,可选择使用1年帕博丽珠单抗免疫治疗。

4 、术后患者很瘦,味觉障碍,如何调理改善?   通常,手术后患者体重会减轻20%左右。这是患者消化吸收能力低下、促食欲的胃肠激素减少引起的。大约6个月到1年时间,患者可以恢复正常。

味觉障碍可能是抗癌药的副作用引起的,也可能是饮食减少导致缺乏锌等微量元素引起的。建议患者采用少食多餐的方式饮食,每天分5-6次吃饭。在日本,我们有时也会给患者用一些营养补充剂。

另外,也可以考虑采用中草药的对症治疗,改善症状,比如十全大补汤、六君子汤。 会诊结束后,李女士的心情得到了极大的平复。她对自己未来要走的路更清晰了,也对日本专家的细致指导和会诊的快速响应非常满意。

中国是消化道癌症发病数量较多的国家,根据国家癌症中心发布的《2022年中国恶性肿瘤疾病负担情况》数据,2022年我国胃癌新发病例约为35.87万例,死亡人数26.04万人。

总体来说,胃癌属于严重威胁我国国民生命健康的蕞常见癌症之一。胃癌如能在早、中期发现,还是有很大机会通过手术实现根治的,患者仍有一定机会得到临床治愈(术后5年不复发即为临床治愈)。

但在胃癌患者中,一部分人会因为【年龄较高】、伴有诸多【基础病】等问题,对手术存有疑虑,担心“下不来手术台”,甚至会放弃手术机会,选择吃药等姑息治疗。这样的选择真的正确吗?现如今的技术能否支持这类老年患者安全手术呢?接下来,我们一起看一个真实案例。

01七旬老人遭遇中期胃癌

一位七十多岁的“老胃病”项女士,因短时间体重骤降(8斤)前往就医。血液检测显示,她有一项指标异常升高。进一步检查发现,她的食道和胃连接的地方(贲门)以及胃的“外墙”(胃壁)都变得异常的厚,而且形状不均匀——这正是胃癌常见的表现。

医生随后通过胃镜检查和病例活检(取一小块组织观察上面的细胞),确诊了老人患有胃癌。由于还没有出现胃以外的远处其他器官的转移,也没有附近淋巴结转移,因此项女士的胃癌分期为中期。虽不是早期,但中期胃癌通常是可以手术的。为项女士提供诊疗的医生也表示,可以通过全胃切除手术实现根治。

但一来项女士已经七十多岁,二来她有20多年的糖尿病(手术伤口会更慢愈合、感染风险高、术后并发症风险高)、右肺还有一枚1.2厘米的肺结节。种种问题让老人和家人们都比较犹豫,担心扛不住治疗,最终“越治越糟”。在这样的背景下,项女士决定找一位足够权威的外科专家,来为自己进行全面评估,看看能不能兼顾好肿瘤根治以及手术的安全性。

不久后,项女士预约了来自日本癌研有明医院消化中心胃外科部长布部创也医生为自己提供指导。

02日本专家咨询内容分享

在充分了解了项女士的病情信息和全部资料后,布部创也医生给出了如下指导建议:首先,患者此前接受的是普通CT而非增强CT,胃镜也没有清晰展示食道上肿瘤具体侵犯的程度,因此很难得出精准的分期判断。

后面患者来癌研有明医院就医时,医疗团队会在治疗前为她做一套非常精细、全面的检查,此后就可以明确肿瘤情况了。届时如果发现患者的分期、肿瘤侵犯的范围确实和现在的结果相同,那么可以通过一个腹腔镜微创手术实现根治,损伤会非常小;如果届时发现肿瘤侵犯食道过多,则需要消化道联合食道外科共同进行胸腔镜手术治疗。

但无论是哪一种情况,患者都可以耐受手术,并且保留一部分胃。癌研有明医院是一家极为擅长肿瘤微创手术的知名癌症专科医院。在胃癌方面,2005年,医院开始导入腹腔镜,2019年又引入了达芬奇手术机器人,患者术后并发症更少了。如今,癌研有明医院98%的外科手术都采用微创。

受益于此,很多在别的医院需要胃全切的胃癌患者,到癌研有明后可以保留一部分胃,还能兼顾临床治愈。这对于术后患者的长期营养摄入和体重维持都很有帮助。布部创也医生所在科室的主要目标之一,正是在做到根治性切除的前提之下,将原本的胃全切术式变为次全胃切除术,尽可能为患者保留一些胃,让他们未来的生活质量得到提升。

那么项女士的糖尿病问题,会不会影响到手术呢?对此,布部创也医生认为完全不必担心,因为对于这类患者,癌研有明医院会进行详细的术前评估,并且有专业团队介入,从生活方式调整和专业治疗入手,帮助患者控制好血糖,让血糖水平达到符合手术的标准,从而降低术后愈合不良风险。

关于肺部的1.2厘米结节,布部医生认为可以暂不处理,无论它到底是良性还是恶性。因为这枚结节属于纯磨玻璃结节,即便是恶性,进展也非常缓慢,并不会快速出现转移扩散。而胃癌根治手术虽然会采用微创方式,但依然会给患者带来一定的负担,如果同时处理肺结节,会导致负担过重、患者难以承受。所以当前蕞好的处理办法,是先集中精力解决胃癌肿瘤,术后安排呼吸科专家为患者进行肺结节诊断,给出随访或手术或根治性放疗的建议。

03项女士术后,是否需要化疗来降低复发风险、争取更大治愈希望?

对此,布部创也医生表示,是否化疗现在还不能判断。因为术后患者能获得蕞精准的分期判断,有可能患者术前被认为是2期,但实际上术后成了1期(无需化疗);有时也可能患者术前是1期,但术后成了2-3期。假如是2-3期,则患者术后需要坚持1年的辅助化疗,大概可以降低10%的复发风险。

当地时间10月29日礼来宣布了Ⅲb期临床试验(TRAILBLAZER-ALZ 6)的积极结果,对于早期症状性阿尔茨海默病成人患者,用改良滴定方案接受donanemab治疗的患者在24周主要终点时,伴水肿/积液的淀粉样蛋白相关影像学异常(ARIA-E)有所减少。

donanemab这个新药在今年7月获批于美国,又在之后获日本厚生劳动省、英国药品和医疗产品监管局批准,用于轻度阿尔茨海默病、轻度认知功能障碍的治疗。donanemab在国内2023年取得突破性治疗药物认定,并纳入优先审评审批程序,目前还在审评审批过程中。

CDE官网截图

但在FDA说明书中有黑框警告,大意是应用该药时应注意淀粉样蛋白相关影像学异常(ARIA),表现为ARIA-E和ARIA伴含铁血黄素沉积(ARIA-H),通常发生在治疗早期,且无症状,很少发生严重和危及生命的事件。本次试验的积极结果和这个黑框警告相关。一起来看详情。

FDA说明书截图

给药方式有哪些改变?会不会影响效果?

TRAILBLAZER-ALZ 6是一项多中心随机双盲Ⅲb期研究,主要研究donanemab的不同给药方案对早期症状性AD患者ARIA-E和淀粉样蛋白清除率的影响,这里的早期AD指的是轻度认知障碍(MCI)和轻度痴呆疾病阶段。

给药方式和既往不同,既往标准给药方案是在前三次输注时接受2瓶(700mg)donanemab,然后再接受4瓶(1400mg);改良滴定方式是患者第一次输注1瓶(350mg),第二次输注2瓶(700mg),第三次输注3瓶(1050mg),此后每次输注4瓶(1400mg)。

研究的主要终点是第24周时患者出现ARIA-E占总参与者的比例,结果显示接受改良滴定方式的患者ARIA-E发生率为14%,而标准给药方案为24%,相对风险降低41%。载脂蛋白E(APOE)是已知的阿尔茨海默病遗传风险因素的携带者,在这些患者中,19%患者在改良滴定时患有ARIA-E,而标准给药方案中为57%,相对风险降低67%。

看到这里你或许也有疑问,虽然ARIA-E的发生风险降低了,但改良滴定方案会不会影响疗效?答案是不会。

与接受标准给药方案的患者相比,改良滴定患者淀粉样斑块和p-tau217减少。改良滴定的患者的淀粉样斑块水平较基线平均降低 67%,而标准给药组患者为69%。

参考来源

1.Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase Ⅲb study.

2.CED官网.

3.A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6).

当地时间10月29日,阿西米尼(asciminib)获美国食品药品管理局(FDA)加速批准[1] ,用于慢性期新诊断的费城染色体阳性慢性粒细胞白血病(Ph+CML)成年患者。CML是一种骨髓和血细胞癌症,通常由费城染色体的异常染色体引起。在一线治疗中,约1/3的患者会出现下列问题:由于不良反应或者治疗无效而停止酪氨酸激酶抑制剂(TKI)治疗。

为了解决这一问题,需要开发新的药物,asciminib就是解决这一困境的新药。早在2022年8月,加拿大药物和卫生技术局(CADTH)建议[2] :“若满足条件,可通过公共药物计划报销asciminib用于治疗费城染色体阳性慢性粒细胞白血病。”

asciminib为何得到FDA的青睐?

本次获批基于一项III期多中心随机研究,研究目的是比较每日80mg的asciminib与TKI治疗的疗效。TKI治疗是接受伊马替尼、尼洛替尼、达沙替尼或博舒替尼任意一种治疗。

共有405名患者被随机分配(1:1)进两组治疗。主要疗效结局指标是48周时的主要分子反应(MMR)率。这个指标是慢性髓性白血病的关键指标,这个比例越高,说明该治疗在基因水平上对疾病的控制效果越好,能够更有效地抑制疾病相关基因的表达,进而有望更好地控制疾病的进展、改善患者的症状和预后。

研究结果显示,48周时MMR率方面,asciminib组中为68%(95% CI: 61, 74),TKI组为49%(95% CI: 42, 56),二者相差19%。细看具体的TKI,入组伊马替尼和其他TKI药物入组比例为1:1;asciminib组的MMR率为69%(95% CI: 59, 78),而伊马替尼组为40%(95% CI: 31, 50),相差近30%(95% CI: 17, 42)。

这个新药安全吗?每周需要打几次药?

根据FDA数据显示,在新诊断和既往接受过治疗的患者,应用新药最常见的不良反应(≥20%)是肌肉骨骼疼痛、皮疹、疲劳、上呼吸道感染、头痛、腹痛和腹泻。若只看新诊断的患者,最常见的实验室异常(≥40%)是淋巴细胞计数降低、白细胞计数降低、血小板计数降低、中性粒细胞计数降低等。

根据FDA已批准的asciminib说明书,用药期间还需要注意一下事项:

1.骨髓抑制 :用药期间可能因出现骨髓抑制,发生血小板减少症、中性粒细胞减少症和贫血。用药应在治疗的前3个月,需要每两周进行一次全血细胞计数,此后每月进行一次检测,从而判断患者有无骨髓抑制症状。根据严重程度,咨询医生是否需要停药。

2.胰腺毒性 :患者可能出现血清脂肪酶和淀粉酶无症状升高,每月需评估血清脂肪酶和淀粉酶水平,如果您有胰腺炎,则注意主动告知医生,需要进行频率更高的检测。

3.高血压风险 :可能出现3级或4级高血压风险,应注意检测血压。

4.超敏反应 :可能出现3级或4级超敏反应,包括皮疹、水肿和支气管痉挛。如果出现这些症状,需及时反馈医生,医生会根据超敏反应的体征和症状,开始适当的治疗。

5.心血管毒性 :如果您有心血管病史,需要告知医生;对于3级或更高级别的心血管毒性,医生会考虑暂停用药、减少剂量或永久停药。

6.胚胎/胎儿毒性 :若您在怀孕期间用药或在服用药物期间怀孕,可能对孩子有潜在风险。这个新药是口服药,需要根据不同的给药剂量(80mg或40mg)每天/或每两天用药。

近些年来,还有哪些白血病药物获批FDA?

根据FDA肿瘤学/血液系统恶性肿瘤批准通知,白血病相关新药整理如下表。

另外可以看出21年时asciminib已获批白血病治疗,但限定既往接受过两种或更多TKIs治疗,本次获批属于扩大适应证。

参考来源:

1.FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia. 2.Asciminib(Scemblix):CADTHReimbursementRecommendation:Indication:ForthetreatmentofadultpatientswithPhiladelphiachromosome-positivechronicmyeloidleukemia(Ph+CML)inchronicphase(CP)previouslytreatedwith2ormoretyrosinekinaseinhibitors.Ottawa(ON):CanadianAgencyforDrugsandTechnologiesinHealth;2022Aug.PMID:38713779. 3.AStudyofOralAsciminibVersusOtherTKIsinAdultPatientsWithNewlyDiagnosedPh+CML-CP. 4.Product information:SCEMBLIX-asciminibtablet,filmcoated.UpdatedAugust7,2024. 5.Oncology(Cancer)/HematologicMalignanciesApprovalNotifications.

以下内容来源于新英格兰医学杂志。

Presentation of Case

Dr. Carrie Chui (Neurology): A 79-year-old man was admitted to this hospital because of involuntary movements on the left side and transient unresponsiveness.
The patient had been in his usual state of health until 9 months before admission, when involuntary movements of the left shoulder and left side of the face developed. The movements were described by the patient as twitching, were not associated with a change in the level of consciousness, and resolved after 1 to 2 minutes. During the next 6 months, the patient had similar episodes approximately once per month, but the episodes increased in duration, lasting 5 to 6 minutes.
Three months before admission, the episodes of involuntary movements increased in frequency, and the patient was evaluated by his primary care physician. The physical examination was normal. Results of kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 129 mmol per liter (reference range, 135 to 145). There was a history of inappropriate antidiuretic hormone secretion, and the sodium level was similar to levels obtained during the past 4 years. Magnetic resonance imaging (MRI) of the head (Figure 1A), performed before and after the administration of intravenous contrast material, revealed a focus of enhancement in the right middle frontal gyrus that was thought to be a small vascular anomaly. Electroencephalography (EEG), performed with the patient in awake and drowsy states, revealed rare, brief, focal slowing in the left temporal lobe during drowsiness; no epileptiform abnormalities were present.
Figure 1
MRI of the Head and CT Angiogram of the Head and Neck.
Two months before admission, the patient was evaluated in the epilepsy clinic affiliated with this hospital. He reported that the episodes of involuntary movements had increased in both frequency and duration, occurring once or twice per day and lasting approximately 10 minutes. Episodes began with tingling and numbness in the left leg that prompted the patient to voluntarily stomp the left foot to relieve the uncomfortable sensation. Then, the patient had involuntary movements that he described as an uncontrollable invisible force moving the left leg and arm, with hyperextension of the arm backward and pronation of the wrist. There was associated numbness in the distal portions of the left third, fourth, and fifth fingers and involuntary movement of the left cheek. No prodromal symptoms occurred. The patient had awareness during the episodes, and after the episodes, he felt fatigued but had a normal level of consciousness, without confusion. The examination in the epilepsy clinic was normal. A diagnosis of seizure disorder was considered, and treatment with levetiracetam was started.
Three weeks before admission, the patient was again evaluated in the epilepsy clinic. He reported that the episodes of involuntary movements still occurred on a daily basis but had decreased in duration and involved only the left leg, without abnormal movements of the arm or face. Dizziness, headache, and weakness had developed and were attributed to the use of levetiracetam. The patient’s family had recorded a video of one of the episodes of involuntary movements. After reviewing the video, the patient’s neurologist thought that the episodes were less likely to be caused by seizures and more consistent with choreoathetoid movements. Cross-tapering of medications — with the simultaneous administration of levetiracetam in decreasing doses and clobazam in increasing doses — was initiated, and the patient was referred to the movement disorders clinic affiliated with this hospital.
On the morning of admission, an episode of involuntary movements of the left leg and left shoulder occurred and persisted for 1 hour. Several hours after the symptoms abated, the patient’s wife found the patient to be unresponsive; he was sitting in a chair. Emergency medical services were called, and when they arrived, the patient was responsive. The fingerstick blood glucose level was 180 mg per deciliter (10.0 mmol per liter) and the blood pressure 110/80 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the patient reported dysuria and increased urinary frequency. The patient’s daughter noted that he had been more anxious during the past 3 years and occasionally had trouble with memory. Other medical history included Barrett’s esophagus, benign prostatic hypertrophy, chronic hepatitis B virus infection, eczema, gastroesophageal reflux disease, hypertension, nonischemic cardiomyopathy, and osteoporosis. There was no history of head trauma or extended loss of consciousness. Medications included aspirin, atorvastatin, doxazosin, finasteride, omeprazole, metoprolol, sacubitril, and valsartan. There were no known drug allergies. The patient was a lifelong nonsmoker and drank alcohol rarely; he did not use illicit drugs. His mother had had gastric cancer, and his sister had had esophageal cancer; there was no family history of seizures.
On examination, the temporal temperature was 36.8°C, the blood pressure 152/97 mm Hg, the pulse 65 beats per minute, the respiratory rate 16 breaths per minute, and the oxygen saturation 96% while the patient was breathing ambient air. The body-mass index (the weight in kilograms divided by the square of the height in meters) was 21.7. The blood pressure decreased to 130/63 mm Hg with standing. The patient was alert and interactive. The lower jaw was held to the left, but the nasolabial folds and smile were symmetric with activation. There were nonrhythmic, nonstereotyped, writhing movements of the left arm. Tone was normal, and strength was assessed as 5 out of 5 in the arms and legs. Results of liver-function and kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 125 mmol per liter. The lactate level was 2.1 mmol per liter (19 mg per deciliter; reference range, 0.5 to 2.0 mmol per liter [5 to 18 mg per deciliter]). The urinalysis was normal. Intravenous fluids were administered. Imaging studies were obtained.
Dr. Rajiv Gupta: Computed tomographic (CT) angiography of the head and neck (Figure 1B) revealed extensively calcified plaque with severe stenosis of the distal right common carotid artery (CCA), extending into the proximal right internal carotid artery (ICA), as well as stenosis of the right and left paraclinoid ICAs and the left vertebral artery at its origin. There was no vascular abnormality on the CT angiogram that corresponded to the abnormality in the right middle frontal gyrus seen on the previous MRI.
Dr. Chui: The patient was admitted to the hospital. On the second hospital day, the sodium level had increased to 130 mmol per liter, and the lactate level was normal. Additional imaging studies were obtained.
Dr. Gupta: MRI of the head showed no evidence of acute infarction. The focus of enhancement in the right frontal lobe that had been noted previously was not seen on the current MRI.
Dr. Chui: Blood levels of thyrotropin, cobalamin, and glycated hemoglobin and results of coagulation tests were normal. Screening tests for Lyme disease, tuberculosis, and syphilis were negative, as were tests for antibodies to cardiolipin and β2-glycoprotein. A test for antinuclear antibodies was positive, at a titer of 1:160 in a homogeneous pattern. During a physical therapy session, the patient had abnormal movements of the left leg, left arm, and left side of the face. The abnormal movements diminished when the patient used distraction techniques, such as thigh tapping, finger snapping, and walking while holding a glass of water.
The transient unresponsiveness that led to the patient’s admission was attributed to a combination of sedation from clobazam and hypovolemia. Treatment with clobazam was stopped, and hydration was encouraged. A diagnosis of functional neurologic disorder was considered; outpatient physical therapy with continued use of distraction techniques was recommended. The patient was discharged home on the third hospital day.
Episodes of involuntary movements continued to occur on a daily basis at home. Two weeks after discharge, when the patient was doing exercises while sitting in a chair and having a conversation with his wife, he suddenly stopped talking. She found him slumped in the chair with his eyes closed, no longer exercising. When she asked him questions, he repeatedly said “yes.” Emergency medical services were called, and when they arrived, the patient was alert, diaphoretic, and nonverbal. He had a facial droop on the left side and a right gaze preference. The fingerstick blood glucose level was 130 mg per deciliter (7.2 mmol per liter) and the blood pressure 120/60 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the temporal temperature was 36.6°C, the blood pressure 143/63 mm Hg, the pulse 66 beats per minute, the respiratory rate 18 breaths per minute, and the oxygen saturation 98% while the patient was breathing ambient air. He was alert and interactive. There was a facial droop on the left side. There was no effort against gravity in the left arm. The patient was able to lift the left leg off the bed for 1 to 2 seconds. He had a right gaze deviation that could not be overcome and mild dysarthria. The remainder of the examination was normal. A diagnosis of stroke was considered, and emergency CT angiography was performed.
Dr. Gupta: CT angiography showed no evidence of acute territorial infarction and no changes in cerebrovascular disease.
Dr. Chui: On repeat physical examination performed after CT angiography, the gaze deviation and dysarthria had resolved, and strength was normal. Mild facial paralysis was present.
A diagnosis was made.

Differential Diagnosis

Dr. Albert Y. Hung: This 79-year-old man initially presented with involuntary movements of the left shoulder and face without associated loss of consciousness. Diagnosis of an unusual movement disorder, especially one that is present episodically, can be challenging. Videos brought in by the patient can be very useful. 1 Most movement disorders result from abnormal functioning of extrapyramidal circuits involving the basal ganglia, rather than a specific neuroanatomical lesion, and the first step toward diagnosis is to identify the type of abnormal movements. 2
Four salient aspects of this patient’s involuntary movements can help in characterizing the movement disorder before generating a differential diagnosis. First, the movements were paroxysmal, lasting for short periods of time with resolution between episodes. Second, the movements were nonstereotyped, appearing randomly and variably. Third, the movements were restricted to the left side of his body throughout the course, localizing the disease process to the right cerebral hemisphere. Finally, the symptoms were progressive, increasing in both duration and frequency.

Movement Disorders

This patient had abnormal involuntary movements, symptoms indicative of a hyperkinetic movement disorder. Tremor, the most common hyperkinetic disorder, is unlikely because the patient did not have rhythmic movements. Dystonia is also unlikely, because he did not have sustained muscle contractions that were causing twisting or abnormal postures of the legs, arms, head, neck, or face. Although the patient initially described the movements as twitching, his later descriptions are not suggestive of myoclonus or tics, which manifest as sudden, rapid, recurrent movements.
This patient’s neurologist described the involuntary movements as “choreoathetoid” after reviewing a video of an episode. Chorea, athetosis, and ballism make up a spectrum of involuntary movements that often occur in combination. Chorea refers to involuntary movements that are “dancelike” — irregular, random, unintended, and flowing from one body part to another. When these movements are slow and writhing (with a lower amplitude) and involve the distal limbs, the term athetosis is used. The presence of both chorea and athetosis in the same patient is referred to as choreoathetosis. When the movements are fast and flinging (with a higher amplitude) and involve the proximal limbs, the term ballism is used. Although the description of this patient’s movements was not clearly suggestive of ballism, hemichorea and hemiballismus often occur together.
The term dyskinesia can refer to any abnormal movements and is often used to describe hyperkinetic disorders that are induced by specific drugs, such as tardive dyskinesia induced by dopamine antagonists or dyskinesia induced by levodopa in patients with Parkinson’s disease. Often, dyskinesia manifests as chorea or choreoathetoid movements, but chorea and dyskinesia are not synonymous. This patient appears to have involuntary dyskinesia with choreoathetosis as the primary phenomenology. Before constructing a differential diagnosis for dyskinesia in this patient, I will consider two conditions that mimic dyskinesia: seizures and functional movement disorder.

Seizures

Various movement disorders may be mistaken for seizures, although these movement disorders are not associated with EEG abnormalities during the episode. Patients with some forms of epilepsy may present with abnormal movements without other features that are typically associated with seizures, such as aura, change in responsiveness, incontinence, or a postictal state. 3,4 Seizures were initially suspected in this patient, and he was referred to the epilepsy clinic. Recurrent focal seizures were probably suspected because of the transient nature of the episodes. Initial MRI had shown a small abnormality in the right middle frontal gyrus, but this finding was not seen on follow-up imaging, which makes it unlikely to be related to the overall presentation. Baseline EEG had shown only brief left temporal slowing, without epileptiform abnormalities. The EEG was an interictal study, so the findings do not rule out seizures. However, the slowing was ipsilateral to the abnormal movements, so it is unlikely to be related to the episodes. In addition, the patient’s involuntary movements were nonstereotyped and nonrhythmic, which makes his presentation unlikely to be due to a seizure disorder.

Functional Movement Disorder

Because this patient’s movements diminished with the use of distraction techniques, a diagnosis of functional movement disorder was considered. Most cases of functional movement disorder begin abruptly after a trigger, such as a mild physical injury or illness; a psychological stressor can be present but is not required for diagnosis. Symptoms are typically most severe around the time of onset and may wax and wane over time. Although distractibility is a finding associated with functional disorders, abnormal movements that occur with nonfunctional syndromes can sometimes be suppressed by action or incorporated into voluntary movements in a manner that may appear distractible. Several clinical features in this patient make a diagnosis of functional disorder unlikely. Functional movement disorder is more common in women than in men, and the average age at onset is 40 years. 5 In addition, tremor is the most common clinical phenotype seen in patients with functional movement disorder; chorea or choreoathetosis, which was seen in this patient, is very unusual in patients with functional movement disorder. Overall, functional movement disorder is unlikely to explain this patient’s presentation.

Dyskinesia

Primary paroxysmal dyskinesia refers to a group of heterogeneous syndromes characterized by recurrent involuntary movements that occur episodically and abruptly, without loss of consciousness. 6 These disorders usually begin in childhood or young adulthood. Both the age of this patient and the described phenomenology make a diagnosis of primary paroxysmal dyskinesia unlikely.
The differential diagnosis in this case is therefore focused on causes of secondary dyskinesia, of which there are many. 7 MRI ruled out the presence of a mass lesion suggestive of cancer. The patient had no history of acute illness suggestive of a viral or other infectious encephalitis, and there was no history of trauma or exposure to drugs or other toxins. Although his daughter mentioned trouble with memory, there was no compelling history suggestive of a neurodegenerative disease.
A common metabolic cause of secondary dyskinesia is diabetic striatopathy, a syndrome involving the acute-to-subacute onset of chorea and ballism in the context of hyperglycemia. 8 This syndrome can occur as the initial manifestation of type 2 diabetes mellitus or as a complication of poorly controlled diabetes. Diabetic striatopathy is more likely to develop in women than in men, and the average age at onset is 70 years. Most patients present with hemichorea and hemiballismus, rather than bilateral symptoms. CT shows hyperdensity, and T1-weighted MRI shows hyperintensity, in the contralateral basal ganglia. However, this patient had no history of diabetes and had a normal blood glycated hemoglobin level, features that rule out a diagnosis of diabetic striatopathy.
Choreiform movements can also be a manifestation of autoimmune conditions. 9 This patient’s initial presentation with unilateral shoulder and face movements would have suggested the possibility of faciobrachial dystonic seizures associated with anti–leucine-rich, glioma-inactivated 1 (anti-LGI1) encephalitis. 10 This condition is often associated with hyponatremia, which was present in this patient. However, as the case evolved, leg involvement and sensory changes developed that would be atypical for anti-LGI1 encephalitis.
One key clue in this case is that the patient did not have an isolated movement disorder. In addition to motor symptoms, he had a variety of sensory symptoms involving both the left arm and the left leg. His first hospital admission was precipitated by an episode of unresponsiveness. The clinical event that led to his second presentation to the emergency department was distinctly different: an acute onset of speech difficulty accompanied by left hemiparesis and right gaze deviation that was worrisome for an acute right middle cerebral artery (MCA) syndrome. The symptoms resolved without intervention, which indicates that he may have had an acute transient ischemic attack (TIA). The most relevant imaging finding was severe cerebrovascular disease, including severe stenosis of the distal right CCA and proximal right ICA. Could this patient’s movement disorder be explained by a vascular lesion?

Limb-Shaking TIAs

Limb-shaking TIAs were first described by C. Miller Fisher in 1962. 11 In most case reports, these episodes are associated with high-grade stenosis of the ICA, which was seen in this patient. 12,13 The mechanism is thought to be cerebral hypoperfusion, and changes in posture or head position that decrease cerebral blood flow can precipitate these episodes. In this patient, the first episode of unresponsiveness that led to hospital admission occurred when he was sitting. He then had an acute episode involving right gaze preference that was provoked by exercise and was very suggestive of a TIA in the right MCA territory. These findings are highly suggestive of a diagnosis of limb-shaking TIAs, and I would refer this patient for emergency carotid endarterectomy.

Clinical Impression and Initial Management

Dr. Scott B. Silverman: When I evaluated this patient, his transient right gaze preference and left hemiparesis were consistent with a right MCA syndrome due to a TIA from symptomatic severe stenosis of the right ICA. The mechanism of this event was either artery-to-artery embolism or hypoperfusion. His previous, recurrent episodes of transient choreoathetosis on the left side that had occurred mainly while he was sitting, standing, or exercising were consistent with limb-shaking TIAs from hypoperfusion or low flow.
The pathogenesis of a low-flow state related to severe carotid stenosis resulting in limb-shaking TIAs is described in a small case series. 14 In six out of eight patients, the transient, stereotyped, involuntary movements were eliminated with carotid artery revascularization. Positional cerebral ischemia in patients without orthostatic hypotension has been described. 15
Treatment with atorvastatin was continued, the dose of aspirin was increased to 325 mg per day, and an intravenous heparin infusion was started. The strategy of permissive hypertension was used, with high blood pressure allowed to a maximum systolic blood pressure of 180 mm Hg. The patient was admitted to the stroke service, and carotid artery duplex ultrasonography was performed.
Dr. Gupta: Doppler ultrasonography of the carotid arteries (Figure 2) revealed markedly elevated Doppler flow velocities within the proximal right ICA. There was a parvus et tardus waveform in the distal right ICA, a finding indicative of low flow related to the more proximal high-grade stenosis. The Doppler waveform contours had poststenotic turbulence.
Figure 2
Doppler Ultrasound Image.
Dr. Silverman: The vascular surgery service was consulted, and the patient underwent right carotid endarterectomy.

Clinical Diagnosis

Limb-shaking transient ischemic attacks.

Dr. Albert Y. Hung’s Diagnosis

Limb-shaking transient ischemic attacks due to severe carotid stenosis, with secondary paroxysmal dyskinesia.

Pathological Discussion

Dr. Caroline F. Hilburn: The endarterectomy specimen included the carotid bifurcation and was notable for firm arterial walls, a finding consistent with calcification. On gross examination (Figure 3A), a large plaque was centered at the carotid bifurcation and protruded into the lumen, resulting in a maximal luminal stenosis of 80%. The plaque had an irregular and focally friable surface. On microscopic examination (Figure 3B), the plaque was characterized by extensive calcification. Some regions of the plaque had a smooth, healed fibrous cap, whereas other regions had an irregular surface suggestive of ulceration, which indicated potential sites of plaque rupture. Multiple smaller calcified plaques were present, affecting both branches of the artery.
Figure 3
Endarterectomy Specimen.

Pathological Diagnosis

Complex atherosclerotic plaque with portions of attached media.

Additional Management

Dr. Silverman: After the procedure, the patient had an uneventful recovery and was discharged home on the fifth hospital day. He was seen 1 month after discharge in the stroke prevention clinic. There had been no further episodes of involuntary movements or choreoathetosis and no stroke or TIA. The patient continues to take aspirin, atorvastatin, and antihypertensive medications.

Final Diagnosis

Limb-shaking transient ischemic attacks.
打开京东APP
实惠又轻松
打开京东APP
京ICP备11041704号
京公网安备 11000002000088号